Grants per year
Personal profile
Research Interests
I am currently conducting research into the genetics of prostate cancer which could lead to new tests for the disease as well as possible new means of treating or preventing prostate cancer. I specialize in prostate cancer surgery and am recognized as an expert in performing the "nerve-sparing" radical prostatectomy that can preserve sexual potency.
Certifications and Licenses
| Urology |
Training Experience
| 1969 | Internship, Yale-New Haven Hospital |
| 1970 | Residency, Univ. of CA-San Francisco Med. Ctr. |
| 1976 | Residency, Johns Hopkins Hospital |
Education/Academic qualification
MD, Yale University School of Medicine
… → 1968
Research interests
- Urology
Fingerprint Dive into the research topics where William J Catalona is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
Prostatic Neoplasms
Medicine & Life Sciences
Prostate-Specific Antigen
Medicine & Life Sciences
Prostatectomy
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Prostate
Medicine & Life Sciences
Early Detection of Cancer
Medicine & Life Sciences
Urinary Bladder Neoplasms
Medicine & Life Sciences
Biopsy
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants 2001 2020
Spherical Nucleic Acids as Therapeutic Vaccines for the Treatment of Prostate Cancer
Catalona, W. J., Kuzel, T. M., Lee, A., Mirkin, C. A. & Zhang, B.
8/31/17 → 8/30/20
Project: Research project
Nucleic Acids
Prostatic Neoplasms
Vaccines
Cancer Vaccines
Technology
CCNE Project #3: Spherical Nucleic Acids as Immunotherapeutic Agents for Prostate (Catalona)
9/1/15 → 7/31/20
Project: Research project
Nucleic Acids
Prostate
Nanostructures
Therapeutics
Neoplasms
Nucleic Acid-Based Nanoconstructs for the Treatment of Cancer
Bagheri, N., Catalona, W. J., Espinosa, H. D., James, C. D., Lee, A., Mirkin, C. A., Mrksich, M., Nguyen, S., Odom, T. W., Platanias, L. C., Stegh, A. H., Woloschak, G. E. & Zhang, B.
9/1/15 → 7/31/20
Project: Research project
Nucleic Acids
Nanostructures
Neoplasms
Therapeutics
Nanotechnology
SPORE Project 1: Impact of Germline Genetic Variants and Failure of Active Surveillance for Prostate Cancer
8/18/15 → 7/31/20
Project: Research project
Prostatic Neoplasms
Neoplasms
Castration
Research Personnel
EphB4 Receptor
Prostatic Neoplasms
Neoplasms
Castration
Research Personnel
EphB4 Receptor
Research Output 1951 2019
1
Citation
(Scopus)
Approaches to urinary detection of prostate cancer
Eskra, J. N., Rabizadeh, D., Pavlovich, C. P., Catalona, W. J. & Luo, J., Sep 1 2019, In : Prostate Cancer and Prostatic Diseases. 22, 3, p. 362-381 20 p.Research output: Contribution to journal › Review article
Prostatic Neoplasms
Urine
Biomarkers
Neoplasms
Research
EPHB4 inhibition activates ER stress to promote immunogenic cell death of prostate cancer cells
Sagar, V., Vatapalli, R., Lysy, B., Pamarthy, S., Anker, J. F., Rodriguez, Y., Han, H., Unno, K., Stadler, W. M., Catalona, W. J., Hussain, M., Gill, P. S. & Abdulkadir, S. A., Nov 1 2019, In : Cell Death and Disease. 10, 11, 801.Research output: Contribution to journal › Article
Open Access
Prostatic Neoplasms
Cell Death
Neoplasms
Adenosine Triphosphate
Calreticulin
1
Citation
(Scopus)
Genistein treatment duration effects biomarkers of cell motility in human prostate
Zhang, H., Gordon, R., Li, W., Yang, X., Pattanayak, A., Fowler, G., Zhang, L., Catalona, W. J., Ding, Y., Xu, L., Huang, X., Jovanovic, B., Kelly, D. L., Jiang, H. & Bergan, R., Mar 2019, In : PloS one. 14, 3, e0214078.Research output: Contribution to journal › Article
Open Access
Genistein
genistein
Biomarkers
cell movement
Cell Movement
5
Citations
(Scopus)
Inflammatory Bowel Disease and the Risk of Prostate Cancer
Burns, J. A., Weiner, A. B., Catalona, W. J., Li, E. V., Schaeffer, E. M., Hanauer, S. B., Strong, S., Burns, J., Hussain, M. H. A. & Kundu, S. D., May 2019, In : European urology. 75, 5, p. 846-852 7 p.Research output: Contribution to journal › Article
Inflammatory Bowel Diseases
Prostatic Neoplasms
Prostate-Specific Antigen
Safety Management
Incidence
13
Citations
(Scopus)
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression
Song, B., Park, S. H., Zhao, J. C., Fong, K. W., Li, S., Lee, Y., Yang, Y. A., Sridhar, S., Lu, X., Abdulkadir, S. A., Vessella, R. L., Morrissey, C., Kuzel, T. M., Catalona, W., Yang, X. & Yu, J., Feb 1 2019, In : Journal of Clinical Investigation. 129, 2, p. 569-582 14 p.Research output: Contribution to journal › Article
LY-2157299
Castration
Androgen Antagonists
Prostatic Neoplasms
Epithelial-Mesenchymal Transition